Literature DB >> 26824366

Genetic Defects of the β-Cell That Cause Diabetes.

Caroline M Stekelenburg, Valerie M Schwitzgebel.   

Abstract

Individuals with higher-than-normal blood sugar levels used to be diagnosed as having either type 1 or type 2 diabetes. We now know that a wide range of different factors can cause diabetes, including single gene defects, which account for at least 1% of all diabetes cases and up to 4% of cases in the pediatric population. However, misdiagnosis remains common due to the considerable clinical overlap between the different diabetes forms. Monogenic diabetes onset can occur shortly after birth, as observed in neonatal diabetes mellitus, or any time later in life. The present chapter outlines the genes currently known to be involved in monogenic diabetes. Some of these genes are involved in β-cell development, with mutations often leading to a decreased β-cell number, while others play important roles in β-cell function and maintenance. Monogenic forms of autoimmune diabetes and epigenetic causes will also be discussed. A genetic diagnosis may influence treatment choice and prognosis determination and may also lead to family counseling. Genetic screening using next-generation sequencing is becoming more practical as it becomes increasingly accessible and less expensive.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 26824366     DOI: 10.1159/000439417

Source DB:  PubMed          Journal:  Endocr Dev        ISSN: 1421-7082


  4 in total

1.  Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes.

Authors:  Helmut Hiller; Dawn E Beachy; Joseph J Lebowitz; Stefanie Engler; Justin R Mason; Douglas R Miller; Irina Kusmarteva; Laura M Jacobsen; Amanda L Posgai; Habibeh Khoshbouei; Richard A Oram; Desmond A Schatz; Andrew T Hattersley; Bernd Bodenmiller; Mark A Atkinson; Harry S Nick; Clive H Wasserfall
Journal:  Diabetes       Date:  2021-05-25       Impact factor: 9.337

2.  Precision medicine in diabetes: A non-invasive prenatal diagnostic test for the determination of fetal glucokinase mutations.

Authors:  Thierry Nouspikel; Jean-Louis Blouin; Jardena J Puder; Bettina Köhler Ballan; Valerie M Schwitzgebel
Journal:  J Diabetes Investig       Date:  2021-09-28       Impact factor: 4.232

3.  Loss of Nexmif results in the expression of phenotypic variability and loss of genomic integrity.

Authors:  Caroline Stekelenburg; Jean-Louis Blouin; Federico Santoni; Norann Zaghloul; Elisabeth A O'Hare; Rodolphe Dusaulcy; Pierre Maechler; Valerie M Schwitzgebel
Journal:  Sci Rep       Date:  2022-08-15       Impact factor: 4.996

4.  Involvement of stanniocalcins in the deregulation of glycaemia in obese mice and type 2 diabetic patients.

Authors:  José Javier López; Isaac Jardín; Carlos Cantonero Chamorro; Manuel Luis Duran; María José Tarancón Rubio; Maria Reyes Panadero; Francisca Jiménez; Rocio Montero; María José González; Manuel Martínez; María Jose Hernández; José María Brull; Antonio Jesús Corbacho; Elena Delgado; María Purificación Granados; Luis Gómez-Gordo; Juan Antonio Rosado; Pedro Cosme Redondo
Journal:  J Cell Mol Med       Date:  2017-10-09       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.